Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0001493152-23-021648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-16 | 2023-06-14 | ABEO | Silverstein Christine Berni | Dir | A - Grant | $4.62 | +58.7K | 94.2K | +165% | +$271.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-14 | A | A | 58,689 | $4.62 | 94,214 | D | — | — | (F1) All of the restricted stock will vest on June 14, 2024. |